These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 29097913)
1. PET Imaging of FSHR Expression in Tumors with Pan D; Liu G; Xu Y; Wang Y; Yue Y; Wang L; Yan J; Wang X; Yang R; Yang M Contrast Media Mol Imaging; 2017; 2017():2674502. PubMed ID: 29097913 [TBL] [Abstract][Full Text] [Related]
2. Pilot study of a novel (18)F-labeled FSHR probe for tumor imaging. Xu Y; Pan D; Zhu C; Xu Q; Wang L; Chen F; Yang R; Luo S; Yang M; Yan Y Mol Imaging Biol; 2014 Aug; 16(4):578-85. PubMed ID: 24389931 [TBL] [Abstract][Full Text] [Related]
3. Prostate cancer imaging of FSHR antagonist modified with a hydrophilic linker. Zhu C; Xu Q; Pan D; Xu Y; Liu P; Yang R; Wang L; Sun X; Luo S; Yang M Contrast Media Mol Imaging; 2016; 11(2):99-105. PubMed ID: 26286841 [TBL] [Abstract][Full Text] [Related]
4. A new (68)Ga-labeled BBN peptide with a hydrophilic linker for GRPR-targeted tumor imaging. Pan D; Xu YP; Yang RH; Wang L; Chen F; Luo S; Yang M; Yan Y Amino Acids; 2014 Jun; 46(6):1481-9. PubMed ID: 24633452 [TBL] [Abstract][Full Text] [Related]
5. Optimizing the performance of Pan D; Wang L; Wang X; Yan J; Xu Y; Yang M Int J Radiat Biol; 2022; 98(10):1571-1580. PubMed ID: 35389307 [TBL] [Abstract][Full Text] [Related]
6. PET imaging of a Xu Y; Wang L; Pan D; Yu C; Mi B; Huang Q; Sheng J; Yan J; Wang X; Yang R; Yang M Br J Radiol; 2019 Dec; 92(1104):20190425. PubMed ID: 31593482 [TBL] [Abstract][Full Text] [Related]
7. [ Zhang P; Zhao Z; Zhang L; Wu W; Xu Y; Pan D; Wang F; Yang M Nucl Med Biol; 2019; 74-75():19-24. PubMed ID: 31450071 [TBL] [Abstract][Full Text] [Related]
8. Preclinical comparison of Al18F- and 68Ga-labeled gastrin-releasing peptide receptor antagonists for PET imaging of prostate cancer. Chatalic KL; Franssen GM; van Weerden WM; McBride WJ; Laverman P; de Blois E; Hajjaj B; Brunel L; Goldenberg DM; Fehrentz JA; Martinez J; Boerman OC; de Jong M J Nucl Med; 2014 Dec; 55(12):2050-6. PubMed ID: 25413139 [TBL] [Abstract][Full Text] [Related]
9. PET of follicle-stimulating hormone receptor: broad applicability to cancer imaging. Hong H; Yan Y; Shi S; Graves SA; Krasteva LK; Nickles RJ; Yang M; Cai W Mol Pharm; 2015 Feb; 12(2):403-10. PubMed ID: 25581441 [TBL] [Abstract][Full Text] [Related]
10. 68Ga-labeling and in vivo evaluation of a uPAR binding DOTA- and NODAGA-conjugated peptide for PET imaging of invasive cancers. Persson M; Madsen J; Østergaard S; Ploug M; Kjaer A Nucl Med Biol; 2012 May; 39(4):560-9. PubMed ID: 22172391 [TBL] [Abstract][Full Text] [Related]
11. PET of tumors expressing gastrin-releasing peptide receptor with an 18F-labeled bombesin analog. Dijkgraaf I; Franssen GM; McBride WJ; D'Souza CA; Laverman P; Smith CJ; Goldenberg DM; Oyen WJ; Boerman OC J Nucl Med; 2012 Jun; 53(6):947-52. PubMed ID: 22570329 [TBL] [Abstract][Full Text] [Related]
12. Radiolabeled B9958 Derivatives for Imaging Bradykinin B1 Receptor Expression with Positron Emission Tomography: Effect of the Radiolabel-Chelator Complex on Biodistribution and Tumor Uptake. Zhang Z; Amouroux G; Pan J; Jenni S; Zeisler J; Zhang C; Liu Z; Perrin DM; Bénard F; Lin KS Mol Pharm; 2016 Aug; 13(8):2823-32. PubMed ID: 27348517 [TBL] [Abstract][Full Text] [Related]
13. Dual-Modality Imaging of Prostate Cancer with a Fluorescent and Radiogallium-Labeled Gastrin-Releasing Peptide Receptor Antagonist. Zhang H; Desai P; Koike Y; Houghton J; Carlin S; Tandon N; Touijer K; Weber WA J Nucl Med; 2017 Jan; 58(1):29-35. PubMed ID: 27516447 [TBL] [Abstract][Full Text] [Related]
14. Synthesis and evaluation of a novel 68Ga-chelate-conjugated bisphosphonate as a bone-seeking agent for PET imaging. Suzuki K; Satake M; Suwada J; Oshikiri S; Ashino H; Dozono H; Hino A; Kasahara H; Minamizawa T Nucl Med Biol; 2011 Oct; 38(7):1011-8. PubMed ID: 21982572 [TBL] [Abstract][Full Text] [Related]
15. Metabolically Stabilized (68)Ga-NOTA-Bombesin for PET Imaging of Prostate Cancer and Influence of Protease Inhibitor Phosphoramidon. Richter S; Wuest M; Bergman CN; Krieger S; Rogers BE; Wuest F Mol Pharm; 2016 Apr; 13(4):1347-57. PubMed ID: 26973098 [TBL] [Abstract][Full Text] [Related]
16. Targeting of MMP2 activity in malignant tumors with a 68Ga-labeled gelatinase inhibitor cyclic peptide. Liu Q; Pan D; Cheng C; Zhang A; Ma C; Wang L; Zhang D; Liu H; Jiang H; Wang T; Xu Y; Yang R; Chen F; Yang M; Zuo C Nucl Med Biol; 2015 Dec; 42(12):939-44. PubMed ID: 26344861 [TBL] [Abstract][Full Text] [Related]
17. Novel radiolabeled peptides for breast and prostate tumor PET imaging: (64)Cu/and (68)Ga/NOTA-PEG-[D-Tyr(6),βAla(11),Thi(13),Nle(14)]BBN(6-14). Fournier P; Dumulon-Perreault V; Ait-Mohand S; Tremblay S; Bénard F; Lecomte R; Guérin B Bioconjug Chem; 2012 Aug; 23(8):1687-93. PubMed ID: 22770480 [TBL] [Abstract][Full Text] [Related]
18. Radiolabeled R954 Derivatives for Imaging Bradykinin B1 Receptor Expression with Positron Emission Tomography. Kuo HT; Pan J; Lau J; Zhang C; Zeisler J; Colpo N; Bénard F; Lin KS Mol Pharm; 2017 Mar; 14(3):821-829. PubMed ID: 28094956 [TBL] [Abstract][Full Text] [Related]
19. In Vivo Evaluation of a Bombesin Analogue Labeled with Ga-68 and Co-55/57. Dam JH; Olsen BB; Baun C; Høilund-Carlsen PF; Thisgaard H Mol Imaging Biol; 2016 Jun; 18(3):368-76. PubMed ID: 26561028 [TBL] [Abstract][Full Text] [Related]
20. PET imaging of prostate tumors with 18F-Al-NOTA-MATBBN. Pan D; Yan Y; Yang R; Xu YP; Chen F; Wang L; Luo S; Yang M Contrast Media Mol Imaging; 2014; 9(5):342-8. PubMed ID: 24729577 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]